SAN DIEGO, May 27, 2014 /PRNewswire/ — Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, will hold a conference call and webcast today to discuss its announcement that it has signed an agreement to acquire AtheroMed, Inc.

The conference call and webcast will begin at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time). The call can be accessed by dialing (631) 291-4555, passcode 52083889, or via the company’s website at www.volcanocorp.com. A replay of the call will be available through Friday, May 30, by dialing (404) 537-3406, passcode 52083889, and via the company’s website.

About Volcano Corporation

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company’s website at www.volcanocorp.com.

SOURCE Volcano Corporation